| 000 | 01728 a2200457 4500 | ||
|---|---|---|---|
| 005 | 20250515202554.0 | ||
| 264 | 0 | _c20100408 | |
| 008 | 201004s 0 0 eng d | ||
| 022 | _a1873-264X | ||
| 024 | 7 |
_a10.1016/j.jpba.2009.12.011 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aSrinivasu, Prabha | |
| 245 | 0 | 0 |
_aA validated stability-indicating LC method for acetazolamide in the presence of degradation products and its process-related impurities. _h[electronic resource] |
| 260 |
_bJournal of pharmaceutical and biomedical analysis _cMay 2010 |
||
| 300 |
_a142-8 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Validation Study | ||
| 650 | 0 | 4 |
_aAcetazolamide _xanalysis |
| 650 | 0 | 4 | _aBuffers |
| 650 | 0 | 4 |
_aCarbonic Anhydrase Inhibitors _xanalysis |
| 650 | 0 | 4 |
_aChromatography, High Pressure Liquid _xstandards |
| 650 | 0 | 4 |
_aChromatography, Reverse-Phase _xstandards |
| 650 | 0 | 4 | _aDrug Contamination |
| 650 | 0 | 4 | _aDrug Stability |
| 650 | 0 | 4 | _aGuidelines as Topic |
| 650 | 0 | 4 | _aHydrogen-Ion Concentration |
| 650 | 0 | 4 | _aHydrolysis |
| 650 | 0 | 4 | _aMagnetic Resonance Spectroscopy |
| 650 | 0 | 4 | _aMass Spectrometry |
| 650 | 0 | 4 | _aOxidation-Reduction |
| 650 | 0 | 4 | _aPhotolysis |
| 650 | 0 | 4 | _aReference Standards |
| 650 | 0 | 4 | _aReproducibility of Results |
| 650 | 0 | 4 | _aSpectroscopy, Fourier Transform Infrared |
| 650 | 0 | 4 |
_aTechnology, Pharmaceutical _xmethods |
| 650 | 0 | 4 | _aTemperature |
| 700 | 1 | _aSubbarao, Devarakonda V | |
| 700 | 1 | _aVegesna, Raju V K | |
| 700 | 1 | _aSudhakar Babu, K | |
| 773 | 0 |
_tJournal of pharmaceutical and biomedical analysis _gvol. 52 _gno. 1 _gp. 142-8 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.jpba.2009.12.011 _zAvailable from publisher's website |
| 999 |
_c19432645 _d19432645 |
||